L929/A
- 1.00 Dollar US$
- Published date: September 30, 2026
-
- Shirley, New York, United States
This Adriamycin-resistant cell line has been developed by exposure of the parent L929 murine fibroblast cell line to increasing concentrations of doxorubicin in-vitro. L929/A cells can be used in the development of novel anti-cancer treatments. Resistance can be circumvented by modulating agents such as verapamil and quinine. The parent cell line L929 was derived from normal subcutaneous areolar adipose tissue.
https://www.creative-bioarray.com/L929-A-CSC-C9505J-item-42514.htm
0 votes
0 votes
Useful information
- Avoid scams by acting locally or paying with PayPal
- Never pay with Western Union, Moneygram or other anonymous payment services
- Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
- This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"
Related listings
-
Mouse Hepatocytes
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Our mouse hepatocytes are prepared using the same careful isolation and cryopreservation techniques as our human lots. Characterization methods of cryopreserved hepatocytes include ECOD, 7-HCG and 7-HCS for phase I and phase II enzyme activities. We ...
-
MC-38
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-6983J Description Established from C57BL/6 mouse colon adenocarcinoma Species Mus musculus (Mouse) Source Intestine; Colon Recommended Medium 90% RPMI-1640 + 10% h.i. FBS https://www.creative-bioarray.com/mc-38-csc-6983j-item-45531.htm
-
CT-26
Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$Cat.No. CSC-C9367L Description Species Mus musculus (Mouse) Source Intestine; Colon Recommended Medium 90% RPMI-1640 + 10% h.i. FBS https://www.creative-bioarray.com/CT-26-CSC-C9367L-item-39544.htm

Loading


